New York bills · 2025 Regular Session
New York A 6927
Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Tony Simone (Democratic)
Cosponsors (20)
- Yudelka Tapia (Democratic)
- Harvey Epstein
- Jessica Gonzalez-Rojas (Democratic/Working Families)
- Karines Reyes (Democratic)
- MaryJane Shimsky (Democratic/Working Families)
- Deborah Glick (Democratic)
- Tommy Schiavoni (Democratic/Working Families)
- Jen Lunsford (Democratic/Working Families)
- Gabriella Romero (Democratic/Working Families)
- Demond Meeks (Democratic/Working Families)
- Harry B. Bronson (Democratic)
- Rebecca Seawright (Democratic)
- Andrew Hevesi (Democratic)
- Jo Anne Simon (Democratic)
- Linda Rosenthal (Democratic)
- Steven Raga (Democratic)
- Grace Lee (Democratic)
- Jordan Wright (Democratic)
- Dana Levenberg (Democratic/Working Families)
- Anna Kelles (Democratic/Working Families)
Summary
Official abstract published by the New York legislature
Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- May 28, 2026 · House
PRINT NUMBER 6927A - May 28, 2026 · House
AMEND (T) AND RECOMMIT TO HIGHER EDUCATION - Jan 7, 2026 · House
REFERRED TO HIGHER EDUCATION - Mar 18, 2025 · House
REFERRED TO HIGHER EDUCATION